Starpharma’s SPL7013 COVID-19 Nasal Spray Virucidal Against SARS-CoV-2
Starpharma (ASX: SPL, OTCQX: SPHRY) today announced it has completed additional antiviral testing for SPL7013 against SARS‘CoV-2 in studies conducted in the laboratory of internationally...

